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1. Introduction 
Advances in genetics in recent years have made major contributions to the development of 
medical genetics. The existence of “familial tumors” has been recognized, and genetic 
testing, with a potentially incalculable benefit to humanity, is being attempted (Offit, 1998). 
Numerous gene analyses related to the genesis and development of colorectal cancer have 
been conducted, and the existence of hereditary colorectal tumors in the form of hereditary 
nonpolyposis colorectal cancer (HNPCC) and familial adenomatous polyposis (FAP) has 
been identified.  
HNPCC is caused by inherited germline mutations in mismatch repair genes and accounts 
for 2 -5% of colorectal cancers. The condition is characterized by young-onset, synchronous 
and metachronous tumors, and a predisposition to gynecologic, urinary tract, and 
extracolonic gastrointestinal cancers. Genetic testing usually begins with a family member 
who has been diagnosed with an HNPCC syndrome-related cancer (proband). If a 
deleterious mutation is identified, testing can be offered to the proband’s family members, 
since they are at risk of carrying the mutation. Knowing one’s genetic risk for hereditary 
cancers may facilitate the early detection or prevention of cancer. 
However, in contrast to the advances in scientific techniques, a great deal of apprehension 
exists with regard to the psychological or ethical, legal, and social issues (ELSI) associated 
with the application of these techniques. Since important personal genetic information that 
does not change throughout one’s lifetime is handled during genetic diagnosis and an 
individual’s genetic information is partly shared with blood relatives, with the impact of 
such genetic information not being limited to the individual, we find ourselves in a situation 
where new life health-care norms that also take psychosocial aspects into consideration are 
required. For this reason, a variety of studies have been conducted regarding the 
psychosocial aspects involved in the screening-test-taking behavior of high-risk people, the 
psychological aspects of high-risk people, interest in genetic counseling and genetic testing, 
and the psychosocial effects of genetic counseling. Studies on psychosocial aspects after 
being informed of the test results have also been reported recently, but many of these 
studies are concerning hereditary breast and ovarian cancer, and very few studies 
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examining the impact of genetic testing for hereditary colorectal tumors have been 
performed.  
In this article, the psychological consequences related to HNPCC are reviewed with regard 
to the following four points: (1) attitude toward genetic testing, (2) risk perception, (3) 
psychosocial effects of genetic counseling, and (4) psychosocial aspects after undergoing 
genetic testing and being informed of the test results. I have reviewed and selected nearly all 
the articles regarding these themes using the PubMed database. 
2. Attitude toward genetic testing 
Many subjects who undergo genetic counseling for HNPCC also wish to undergo genetic 
testing. However, some subjects refuse to undergo genetic testing, despite its potential 
benefits. Some previous studies investigated the relationships between the intention to 
undergo genetic testing and psychosocial variables. 
Hadley et al. (2003) investigated attitudes, intention, and the completion of genetic testing 
among 111 newly identified family members (first-degree relatives) of individuals with 
HNPCC. Most (97%) stated their intention to pursue testing. Fifty-one percent reported that 
learning about their children’s risks was the most important reason to consider testing. The 
participants’ intentions to pursue genetic testing were significantly affected by concerns 
regarding their ability to handle the emotional aspects of testing and the psychosocial effect 
on family members. On the other hand, 39% identified the potential effect on their health 
insurance as the most important reason not to undergo testing. 
Wakefield et al. (2007a) qualitatively assessed 22 individuals’ attitudes toward genetic 
testing for HNPCC. The most frequently reported pros were “to help manage my risk of 
developing cancer”, “to help my family”, and “to know my cancer risk.” The participants 
expressed concern about the potential psychological impact of genetic testing. The authors 
also found that some affected individuals may not fully comprehend the meaning of their 
potential test results. 
Wakefield et al. (2008) conducted a randomized trial to measure the effectiveness of a 
tailored decision aid designed specifically to assist individuals to make informed decisions 
regarding genetic testing for HNPCC. The decision aid explains the evidence available 
regarding HNPCC-related cancer risks, the differences between a mutation search and 
predictive testing, and the potential benefits, risks, and limitations of testing (Wakefield et 
al., 2007b). One hundred and fifty-three individuals were randomly assigned to a group 
who received the decision aid or a group who received a control pamphlet. Evaluations 
were conducted 1 week after consultation and 6 months after the completion of the 
intervention using a questionnaire, and 95 subjects completed the 6-month follow-up 
questionnaire. Although the decision aid had no significant effect on the actual genetic 
testing decision, the participants who received the decision aid had significantly lower 
levels of decisional conflict regarding genetic testing and were more likely to be classified as 
having made an informed choice concerning genetic testing than participants who received 
a control pamphlet. Furthermore, men who received the decision aid had significantly 
higher knowledge levels regarding genetic testing than men who received a control 
pamphlet. 
These reports suggest that most individuals pursue genetic testing to help manage their own 
risk of developing cancer and to learn about their children’s risks. On the other hand, 
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however, concerns about psychological and psychosocial issues may present barriers to 
undergoing genetic testing. The development of patient education tools, such as the decision 
aid, is needed. 
3. Risk perception 
HNPCC mutation carriers have a life-time risk of colorectal cancer of about 80%, while 
female carriers have a 40-60% risk of endometrial cancer and a 10-15% risk of ovarian 
cancer. Communicating cancer risk and assessing the perceived risk is very important for 
genetic counseling because of subsequent cancer prevention behavior or cancer-related 
distress. Four reports were extracted regarding risk perception among individuals at risk for 
HNPCC. 
Codori et al. (2005) assessed the effect of genetic counseling on perceived lifetime risk and 
cancer-distress among 101 adult first-degree-relatives of colorectal cancer patients from 
families with known or suspected HNPCC. Most persons overestimated their cancer risk, 
and a higher perceived risk was associated with believing that colorectal cancer cannot be 
prevented. The individual perceived risk changed after counseling, although the mean 
perceived risk was unchanged. 
Domanska et al. (2007) investigated the perceived cancer risk among 47 HNPCC mutation 
carriers and correlated the findings with individual characteristics. A perceived risk of 
colorectal cancer above 60% was reported by 49% individuals, and only one reported a 
perceived risk > 80%. Female mutation carriers, individuals under the age of 50 years, and 
individuals who received their counseling within 1 year prior to the study reported a higher 
perceived risk of colorectal cancer. Individuals who had lost a parent to HNPCC-related 
cancer at an early age also reported a higher perceived risk. Regarding gynecological cancer, 
33% of the women reported a perceived risk of 40-60% for endometrial cancer, whereas the 
remaining 67% either underestimated or overestimated their risk. 
van Oostrom et al. (2007) studied the difference in cancer risk perception among 271 
individuals who opted for genetic cancer susceptibility testing for a known familial 
BRCA1/2 or HNPCC related germline mutation. The assessment was conducted before, 1 
week after, and 6 months after disclosure of the test results. Individuals from BRCA1/2 and 
HNPCC mutation families did not differ with regard to their risk perceptions over time. 
Individuals from BRCA1/2 families perceived hereditary cancer as being more serious. 
Grover et al. (2009) examined colorectal cancer risk perception among individuals tested for 
mismatch repair genes mutation and identified factors associated with an appropriate 
interpretation of their cancer risk. In this study, in particular, the authors paid attention to 
individuals with an indeterminate genetic test result. Pathogenic mutations in MLH1 and 
MSH2 have been identified in only 30% to 64% of families who meet the clinical criteria for 
HNPCC and have undergone testing. Genetic testing may not yield a definitive result 
because of the lack of an identifiable mutation in one of the known genes or a mutation of 
unclear pathogenic significance. In the absence of an identified family mutation, these 
results are considered indeterminate or uninformative. Patients remain at an increased risk 
for colorectal cancer, and intensive cancer screening recommendations are made based on 
their personal and family cancer histories. A total of 159 individuals who met the Revised 
Bethesda Guidelines and had previously undergone genetic testing participated in this 
study. Ninety individuals with a pathogenic mutation (true positive) correctly estimated 
their cancer risk. However, only 62% of individuals with an indeterminate genetic test result 
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correctly estimated their risk. Individuals with a history of HNPCC-associated cancer or 
indeterminate genetic test results were significantly less likely to estimate their cancer risk 
as being increased. 
These reports suggest that despite educational efforts and an increasing amount of data on 
the risk of cancer associated with HNPCC, few individuals report a perceived risk that is 
actually correct. In particular, individuals at risk for HNPCC who receive an indeterminate 
genetic test result may be falsely reassured. It is important that health care providers 
continue to device a counseling approach for promoting a correct understanding of cancer 
risk and for discussing the implications of uninformative results on the lifetime cancer risk. 
4. Psychosocial effects of genetic counseling 
Cancer genetic counseling has become popular as a result of the recent development of 
genetic tests that pinpoint familial cancer risk. Such counseling is composed of 
presymptomatic risk assessment and management (cancer risk counseling) and 
reproductive risk counseling. The former has two components: risk assessment and 
counseling regarding behavioral, medical, and surgical options to decrease risk. A basic goal 
of cancer risk counseling is to derive and explain an individual’s cancer risk in clear terms, 
and the counselor’s role is to educate and enumerate options for patients and clinicians, 
answer questions regarding what is known, and suggest appropriate referrals to help 
individuals reach difficult decisions. 
A cancer risk counseling session is comprised of the following components: 1) baseline risk 
perception; 2) medical history and exposure history; 3) pedigree construction and pedigree 
documentation; 4) empiric risk assessment and genetic risk assessment; 5) options for early 
detection and prevention; 6) options, risks, and benefits of genetic testing; and 7) response to 
questions, support, and plans for follow-up. Throughout these discussions, a sensitivity to 
the psychological and ethical aspects of counseling is essential. Therefore, continued follow-
up by the counselor after the session is the best way to limit the potential for adverse effects 
as a result of the knowledge of an inherited cancer risk, and ready access to liaison mental 
health professionals with experience in cancer genetics is thought to be a valued asset of 
cancer risk counseling.  
Psychological research on aspects of cancer genetic counseling has focused on three broad 
areas: factors predicting interest in cancer genetic testing (Lerman et al., 1996), the 
psychological impact and effect of genetic counseling and testing for inherited cancer risk 
(Lerman et al., 1997), and the relationship between psychological distress and preventive 
behaviors (Kash et al., 1992). In each of these areas, the results have implications for the 
management of at-risk individuals. However, such data is unlikely to be applicable to every 
case because of cultural differences among study populations and the complexity of the 
instruments used in research studies, in addition to the fact that most of these studies have 
been performed for hereditary breast cancer. In this section, four studies on the 
psychological impacts of genetic counseling regarding HNPCC are reviewed. 
Keller et al. (2002) explored distress before and after comprehensive interdisciplinary 
counseling in families at risk for HNPCC. Sixty-five individuals (31 patients with colorectal 
cancer and 34 unaffected at-risk persons) participated in this study. Data were collected 
from semi-structured questionnaires before, as well as 4-6 weeks after counseling. Distress 
declined after counseling, as did worries related to HNPCC. A trend toward a greater 
anticipated ability to cope with a positive gene test was also observed after counseling. 
Changes after counseling were generally more pronounced for persons at risk, compared 
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with those for patients with cancer. A substantial minority, however, said that they 
experienced increased worry and physical symptoms after counseling.  
Bleiker et al. (2007) examined: 1) levels of cancer-specific distress more than one year after 
genetic counseling for HNPCC; 2) associations between sociodemographic, clinical and 
psychosocial factors and levels of distress; 3) the impact of genetic counseling on family 
relationships; and 4) the social consequences of genetic counseling. One hundred and 
sixteen individuals who participated in this study completed a self-report questionnaire by 
mail an average of 4 years after the last counseling session. Among all the subjects, 6% had 
clinically significant levels of cancer-specific distress (Impact of Event Scale). Having had 
contact with a professional psychosocial worker for cancer risk in the past 10 years was 
significantly associated with higher levels of current cancer specific distress. Only a minority 
of the subjects reported any adverse effects of genetic counseling on communication 
regarding genetic counseling with their children, family relationships, obtaining life 
insurance, choice or change of jobs, and obtaining a mortgage. 
Keller et al. (2008) conducted a prospective study that examined the impact of 
multidisciplinary risk counseling on the psychosocial outcome of 139 affected cancer 
patients and 233 family members without cancer but at risk for HNPCC. Participants 
completed questionnaires specific to HNPCC before and 8 weeks after attending the cancer 
clinic. The levels of distress among affected patients exceeded those of unaffected 
individuals, as did worry regarding their relatives' risk. A significant reduction in general 
anxiety (Hospital Anxiety and Depression Scale), distress specific to familial colorectal 
cancer (Impact of Events Scale), and general cancer worry (Distress due to Hereditary 
Disorder) was demonstrated after counseling among both the affected patients and 
unaffected individuals. The reduction in distress was more pronounced among affected 
patients given a high risk of HNPCC than among those with an intermediate risk. 
Hasenbring et al. (2011) prospectively examined the impact of an initial interdisciplinary 
genetic counseling on feelings of anxiety with a special focus on subgroups related to 
personal cancer history, sex, age, and education. A significant interaction between time, sex, 
and age was identified for change in anxiety. While women in general and men older than 
50 years revealed a significant reduction in anxiety, younger men did not show any change 
over time. A logistic regression analysis indicated that clinical Hospital Anxiety and 
Depression Scale-A cases could be predicted based on general distress (Brief Symptom 
Inventory) as well as by HNPCC-related cognitions of intrusion and avoidance (Impact of 
Event Scale) with a correct classification of 86%. 
These studies indicate that anxiety and cancer-specific distress are reduced after genetic 
counseling, suggesting an overall beneficial impact of comprehensive counseling. On the 
other hand, a minority of individuals, such as cancer-affected younger men, exhibited 
adverse effects of genetic counseling on psychosocial variables. Thus, healthcare providers 
(genetic counselors, human geneticists, oncologists, and psycho-oncologists) should always 
be aware of psychosocial issues after genetic counseling. However, as little data is available 
on the psychosocial effects of genetic counseling regarding HNPCC, further data 
accumulation is needed. 
5. Psychosocial aspects after being informed of genetic test results 
Since 1991, when a gene for hereditary cancer was first identified, studies expressing 
concern about the psychosocial aspects of gene diagnosis began in Western countries, with 
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the results starting to be reported in 1993. Although studies investigating psychosocial 
aspects after the subjects had undergone actual genetic testing and had been informed of the 
test results have been reported, many of these studies have concerned hereditary breast and 
ovarian cancer, and only a few studies have been performed for HNPCC. Furthermore, little 
is known about the factors associated with psychosocial aspects. However, HNPCC testing 
might offer more benefit than hereditary breast and ovarian cancer testing because of the 
differences in the risk management options available to mutation carriers. In HNPCC, a 
colonoscopy every 1–2 years is more effective for detecting and preventing adverse health 
outcomes than measures available to carriers of hereditary breast and ovarian cancer 
mutations. Therefore, identifying the psychosocial situations in which individuals at risk 
for colorectal cancer have lived after the disclosure of genetic information or the way in 
which healthcare providers are able to support the mental states of these individuals are 
important. 
Ten original articles (review articles were not included) assessing psychosocial aspects after 
individuals had been informed of genetic test results regarding HNPCC were extracted. In 
this chapter, cross-sectional studies that assessed psychosocial aspects at one time point after 
disclosure and prospective studies that followed-up psychosocial aspects for 1 year or 
longer after disclosure are described separately. A summary is shown in Table 1. 
5.1 Cross-sectional studies assessing psychosocial aspects after the subjects had 
been informed of the test results 
Four articles were extracted. Esplen et al. (2001) investigated psychosocial function in 50 
individuals who were engaged in the genetic test process for HNPCC (the period between 
the psychosocial assessment and the disclosure of the test results was 1 – 48 months). 
Twenty-three individuals were identified as carriers (13 had a previous history of CRC), 
seven were non-carriers and 20 individuals were still awaiting their test results. The 
psychosocial scores demonstrated that a subgroup of individuals exhibited distress, with 
greater distress for those individuals awaiting results or testing positive. A high level of 
satisfaction was associated with the experience of testing. 
Claes et al. (2004) assessed the short-term impact (1month after test result disclosure) of 
genetic testing using a semi-structured interview and self-reported questionnaires. The 
subjects were 40 cancer-unaffected relatives who had undergone predictive testing for 
HNPCC. Distress was within the normal ranges. Distress decreased significantly from pre- 
to post-test in non-carriers but not in carriers. 
Murakami et al. (2004) identified the prevalence rates and predictors of psychological 
distress and evaluated the feelings of guilt at one month after the disclosure of test results in 
Japanese probands and unaffected relatives. The prevalence of major and minor depression, 
acute stress disorder (ASD), posttraumatic stress disorder (PTSD), and posttraumatic stress 
symptoms (PTSS) were assessed using the Structured Clinical Interview based on the 
Diagnostic and Statistical Manual of Mental Disorders, 3rd edition revised (DSM-III-R) or 
the DSM-IV; feelings of guilt were investigated using a numeric scale and a semi-structured 
interview. Forty-two participants completed the 1-month follow-up interview. Although 
none of the participants met the criteria for major depression, ASD, or PTSD at the time of 
the follow-up interview, 7% of the participants met the criteria for minor depression and 5% 
had PTSS. The only predictor of psychological distress was the presence of a history of 
major or minor depression. Twelve percent of the participants had feelings of guilt. 
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CES-D: Center for Epidemiological Studies-Depression, IES: Impact of Event Scale (IES-R: Impact of 
Event Scale-Revised), HADS: Hospital Anxiety and Depression Scale, 
QLI: Quality of Life Index, SCL-90: Symptom Checklist, STAI: State-Trait Anxiety Inventory 
ASD: acute stress disorder, PTSD: post-traumatic stress disorder, PTSS: post-traumatic stress symptoms 
Table 1. Characteristics of studies on psychosocial aspects and associated factors after being 
informed of genetic test results regarding HNPCC 
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Yamashita et al. (2008) elucidated the psychological impact at one month after the disclosure of 
genetic test results regarding HNPCC and assessed the associated factors, focusing on memory 
function in particular. The subjects were persons who were suspected of having HNPCC and 
had been given the choice of undergoing genetic testing. The post-genetic testing 
psychological impact was evaluated using the Impact of Event Scale-Revised (IES-R), and 
personality tendencies and memory function were evaluated. Final data were obtained from 
46 Japanese probands and unaffected relatives (mutation-positive in 18 subjects, uninformative 
in 18 subjects, and mutation-negative in 10 subjects). A comparison of the IES-R scores showed 
that they tended to be higher in the mutation-positive group, but the differences were not 
statistically significant. The personality tendency “nervousness” and the verbal memory 
assessed prior to disclosure were significantly associated with the total IES-R score. 
5.2 Prospective studies assessing psychosocial aspects after the subjects had been 
informed of the test results 
Six articles were extracted. Aktan-Collan et al. (2001) assessed general anxiety, fear of cancer 
and death, satisfaction with life, and attitude regarding the future using a questionnaire 
survey in 271 individuals with no personal cancer history who were tested for HNPCC. 
Measurements were made before the first counseling (baseline), at the test disclosure 
session, and 1 and 12 months after disclosure. Although the mutation-positive individuals 
were more afraid of cancer than those who were mutation negative at every measurement 
point, the fear of cancer decreased significantly from the baseline until after disclosure in 
both groups. The mutation-positive subjects were more anxious than their counterparts 
immediately after the test disclosure, but the differences had disappeared at the follow-up 
examinations. Regarding the other variables, no differences among the groups defined 
according to mutation status or changes over time were detected.  
Meiser et al. (2004) assessed the psychological impact of predictive genetic testing for 
HNPCC in 114 individuals with no personal cancer history (32 carriers and 82 non-carriers) 
using mailed self-administered questionnaires prior to and 2 weeks, 4 months and 12 
months after the disclosure of the test results. Compared with the baseline results, carriers 
showed a significant increase in the mean scores for intrusive and avoidant thoughts 
regarding colorectal cancer at 2 weeks after test result disclosure and a significant decrease 
in the mean depression scores at 2 weeks and 4 months after test result disclosure. For non-
carriers, significant decreases in the mean scores for intrusive and avoidant thoughts 
regarding colorectal cancer were observed at all follow-up assessment time points relative to 
the baseline. Non-carriers also showed significant decreases from the baseline in the mean 
depression scores at 2 weeks, 4 months and 12 months after test result disclosure. Significant 
decreases in the mean state anxiety scores from the baseline were also observed for non-
carriers at 2 weeks after test result disclosure. 
Gritz et al. (2005) examined the impact of HNPCC genetic test results on the psychological 
outcomes of cancer-affected and -unaffected participants up to 1 year after test result 
disclosure. A total of 155 persons completed the study measures before HNPCC genetic 
testing and at 2 weeks and 6 and 12 months after the disclosure of the test results. The mean 
scores for all the outcome measures remained stable and within the normal limits for cancer-
affected participants, regardless of the mutation status. Among unaffected carriers of 
HNPCC-predisposing mutations, the mean depression, state anxiety, and cancer worry 
scores increased from baseline to 2 weeks after test result disclosure and decreased from 2 
weeks to 6 months after test result disclosure. Among unaffected non-carriers, the mean 
depression and anxiety scores did not differ, but the cancer worry scores decreased during 
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the same time period. Affected and unaffected carriers had higher mean test-specific distress 
scores at 2 weeks after test result disclosure, compared with non-carriers, in their respective 
groups; the scores decreased for affected carriers and all unaffected participants from 2 
weeks to 12 months after test result disclosure. Higher levels of baseline mood disturbance, 
a lower quality of life, and lower social support were associated with a risk for both short- 
and long-term increases in distress.  
Claes et al. (2005) evaluated distress one year after the disclosure of a predictive genetic test 
result for HNPCC in 72 cancer-unaffected relatives (36 carriers and 36 non-carriers). The 
mean levels of distress (cancer-specific distress, state anxiety, and psychoneuroticism) were 
within the normal ranges and none of the participants had an overall pattern (on all scales) 
of clinically elevated levels of distress. Carriers had significantly higher cancer-related 
distress one year after test result disclosure than non-carriers. In both groups, colorectal 
cancer-related distress decreased. Non-carriers additionally showed decreased endometrial 
cancer-related distress and state anxiety. 
Collins et al. (2007) conducted a 3-year study of individuals who received predictive genetic 
test results for previously identified familial mutations regarding HNPCC. Questionnaires 
were sent before attendance and 2 weeks, 4 months, 1 year, and 3 years after receiving the 
test results. Psychological measures were included each time. The study included 73 
individuals with no personal cancer history (19 carriers and 54 non-carriers). The results 
showed an increase in mean cancer-specific distress in carriers at 2 weeks with a return to 
baseline levels by 12 months. This level was maintained until 3 years. Non-carriers showed 
sustained decreases after testing with a significantly lower level at 3 years compared with at 
baseline. These scores tended to be lower than those for carriers at 3 years. The mean 
depression and anxiety scores did not differ between carriers and non-carriers and, at 3 
years, were similar to the baseline scores. 
Shiloh et al. (2008) assessed the emotional effects of genetic testing for HNPCC at baseline 
before testing and again at 6 and 12 months after testing. The subjects were 253 cancer-
affected and -unaffected individuals. Negative emotional reactions were evaluated using the 
Revised Impact of Event Scale and the Center for Epidemiological Studies-Depression Scale. 
Monitoring coping style was assessed at baseline using the Miller Behavioral Style Scale. 
Mean reductions were indicated in distress and depression levels within the first 6 months 
after testing. High monitors (individuals who vigilantly attended to threatening cues in their 
environment in an attempt to emotionally process the situation and who actively engaged in 
information seeking and cognitive problem solving with the intention of taking precautions) 
were generally more distressed than low monitors, specifically if they had indeterminate or 
positive results. 
5.3 Summary 
Many studies have shown that genetic testing does not result in short- or long-term 
significant adverse psychological outcomes, including depression, anxiety, and 
posttraumatic stress disorder (PTSD), in either carriers or non-carriers or in either cancer-
affected or cancer–unaffected individuals. However, healthcare providers should assess 
psychological responses, such as minor depression, posttraumatic stress symptoms (PTSS), 
and feelings of guilt, particularly in individuals who have a history of major or minor 
depression, nervous personality tendencies, baseline mood disturbances, a lower quality of 
life, or lower social support. 
Lastly, two cases that showed adverse psychological reactions after being informed of 
genetic test results will be presented. The first case is a man who was diagnosed as having 
www.intechopen.com
 Colorectal Cancer – From Prevention to Patient Care 
 
98
acute stress disorder at a 1-month follow-up examination after the disclosure of a genetic 
test result, despite the fact that the test result had been negative. The second case is a man 
who felt guilty after hearing of the positive test results of family members of individuals 
belonging to his support group. 
5.4 Cases exhibiting adverse psychological reactions 
[Case 1] Mr. A was a 39-year-old married man without children who came for genetic 
counseling and testing because of a family history of colon cancer. He had no history of 
cancer, but his father had a history of colon cancer and his sister had died of the disease at 
an early age. To confirm the diagnosis of HNPCC, a blood sample was obtained and 
mutations in the hMSH2 and hMLH1 genes were analyzed. He then consented in writing to 
participate in our study, and a baseline interview was conducted. He did not meet any of 
the criteria for any psychiatric disorders. 
Approximately two months after the blood test, he underwent post-test counseling and was 
informed that no mutations had been detected in either the hMSH2 or hMLH1 gene. Four 
weeks after the disclosure of the test result, at a 1-month follow-up examination, he was 
diagnosed as having acute stress disorder according to a structured clinical interview based 
on the DSM-IV. The total score of the Impact of Event Scale-Revised was high. The score for 
Total Mood Disturbance in the Profile of Mood States was higher than that at the baseline 
interview. He reported that although he felt emotional relief to learn the negative result, his 
worries regarding colon cancer had increased instead of disappearing. 
Mutation-negative individuals often choose not to participate in follow-up counseling after 
genetic testing. However, this case suggests that it is important to evaluate the psychological 
outcome after genetic testing regardless of the test result, and that psychiatrists or 
psychologists should support the genetic counseling system. 
[Case 2] Mr. B, a 59-year-old man, underwent a total colectomy for the resection of colorectal 
cancer. He and his 25-year old son requested predictive genetic testing 3 years later to 
reduce uncertainty and to help plan his son’s future, since Mr. B’s mother had died of colon 
cancer secondary to HNPCC. Mr. B and his son were provided with both an educational 
session explaining the genetics of hereditary diseases and counseling regarding the possible 
impact of positive test results. The tests revealed the presence of a mutation in the father but 
not in the son. Mr. B was relieved that his “bad blood” had not been passed on to his son. 
Later, however, he began to experience anhedonia and became depressed for several days. 
His primary care physician could not determine the reason for his feelings. 
Mr. B was the chairperson of a hereditary cancer patient support group run by patients, 
their families, and health care providers. The group had been established to help families 
with hereditary cancer exchange information and experiences. Mr. B began to feel guilty 
because his son had tested negative while the family members of others in his support 
group had tested positive for the disease. 
6. Conclusion 
Cancer genetic counseling and genetic testing for HNPCC are now conducted in ordinary 
clinical settings. However, as mentioned above, few studies have examined the psychosocial 
aspects of genetic testing for HNPCC, and psychosocial assessments and long-term follow-
up care for individuals who have undergone genetic counseling or testing and at-risk 
relatives with no personal history of cancer remain insufficient. To develop this field, the 
following problems should be examined: 1) the development of a cancer genetic counseling 
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model, including psychosocial support; 2) the education of cancer genetic counselors; 3) the 
availability of appropriate information concerning cancer genetics; 4) the recruitment of 
subjects at risk for cancer susceptibility; and 5) the accumulation of further psycho-oncology 
research results. While it is by no means easy to deal with these problems, it is essential that 
medical oncologists, surgical oncologists, psycho-oncologists, medical geneticists, nurses, 
and all other health care providers involved in cancer care vigorously approach this new 
area in collaboration with one another. 
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